Business

DOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc.

DOMA Perpetual Capital Management LLC (together with its affiliates, "DOMA"), which beneficially owns approximately 6.83% of the outstanding shares of Common Stock of Pacira BioSciences, Inc. (NASDAQ: PCRX) ("Pacira" or the "Company"), today announced that it intends to nominate three highly-qualified, independent director candidates at the Company's 2026 annual meeting of stockholders. DOMA further asserts the Company's Board of Directors should pursue an immediate sale of the Company. DOMA con

articlePacira Biosciences, Inc.December 30, 20253/company/pacira-biosciences-inc/news/doma-perpetual-capital-management-announces-intent-to-nominate-three-highly-qualified-independent-director-candidates-at-2026-annual-meeting-of-pacira-biosciences-inc
DOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc.

About this update from Pacira Biosciences, Inc.

[{"type":"text","content":"Restates Position that Pacira's Board Should Conduct Formal Sales Process of the Business","length":93,"tagName":"p","attribs":{}},{"type":"text","content":"Considers Current Executive Compensation and Spending Exorbitant and Unmerited ","length":78,"tagName":"p","attribs":{}},{"type":"text","content":"Questions Whether the Board Has Exercised Appropriate Fiduciary Oversight","length":73,"tagName":"p","attribs":{}},{"type":"text","content":"MIAMI, Dec. 30, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC (together with its affiliates, "DOMA"), which beneficially owns approximately 6.83% of the outstanding shares of Common Stock of Pacira BioSciences, Inc. (NASDAQ: PCRX) ("Pacira" or the "Company"), today announced that it intends to nominate three highly-qualified, independent director candidates at the Company's 2026 annual meeting of stockholders. DOMA further asserts the Company's Board of Directors should pursue an immediate sale of the Company. DOMA considers the current level of Executive Compensation and General Spending to be exorbitant and unmerited and questions whether the Board has exercised appropriate fiduciary oversight.","length":761,"tagName":"p"},{"type":"image","alt":"DOMA Perpetual Capital Management LLC (PRNewsfoto/DOMA Perpetual)","displaySize":"","headline":null,"caption":"DOMA Perpetual Capital Management LLC (PRNewsfoto/DOMA Perpetual)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":118,"url":"https://media.zenfs.com/en/prnewswire.com/1e8ded2293e965ad361d9ce30d6866e3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mBDC5o8PTlSh9ScAUstjsg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIwODtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/1e8ded2293e965ad361d9ce30d6866e3","width":400,"height":118}},"href":"https://mma.prnewswire.com/media/2468496/DOMA_Perpetual_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"About DOMA Perpetual Capital Management LLC:DOMA Perpetual Capital Management LLC is an asset management firm based in Miami, Florida. DOMA Perpetual strives to achieve great investment results by identifying attractive, uncorrelated companies with sustainable competitive advantages, while limiting exposure to downside risks. It employs an opportunistic, fundamentals-based strategy that...

More updates from Pacira Biosciences, Inc.

DOMA Perpetual Capital Management LLCDOMAPerpetual Capital Management LLCoutstanding sharesCommon Stock